Clinical Trial Update: A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing the effect of PF-03893787 on lung function after an allergen challenge in asthmatic subjects; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PF-03893787

Snippet

Sponsor: Pfizer | Conditions: Asthma | Phase 1 | Status: COMPLETED